Rasika Mathias
Concepts (743)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 88 | 2025 | 1333 | 5.220 |
Why?
| Polymorphism, Single Nucleotide | 101 | 2025 | 2073 | 4.640 |
Why?
| Genetic Predisposition to Disease | 67 | 2025 | 2282 | 3.660 |
Why?
| Peanut Hypersensitivity | 6 | 2023 | 140 | 3.070 |
Why?
| Asthma | 49 | 2025 | 2230 | 2.950 |
Why?
| Whole Genome Sequencing | 26 | 2025 | 130 | 2.440 |
Why?
| Dermatitis, Atopic | 9 | 2023 | 319 | 2.310 |
Why?
| Precision Medicine | 20 | 2025 | 387 | 2.230 |
Why?
| Genetic Variation | 30 | 2025 | 937 | 2.090 |
Why?
| Food Hypersensitivity | 4 | 2023 | 176 | 2.050 |
Why?
| Fatty Acid Desaturases | 12 | 2021 | 32 | 2.020 |
Why?
| Immunoglobulin E | 18 | 2021 | 329 | 1.870 |
Why?
| Genome, Human | 19 | 2025 | 393 | 1.870 |
Why?
| Arachis | 5 | 2023 | 109 | 1.840 |
Why?
| Platelet Aggregation | 12 | 2021 | 95 | 1.800 |
Why?
| Induced Pluripotent Stem Cells | 4 | 2021 | 221 | 1.720 |
Why?
| Genotype | 42 | 2025 | 1839 | 1.690 |
Why?
| Exome | 14 | 2022 | 220 | 1.660 |
Why?
| Blood Platelets | 12 | 2022 | 380 | 1.530 |
Why?
| Alleles | 22 | 2023 | 845 | 1.450 |
Why?
| Kaposi Varicelliform Eruption | 4 | 2021 | 21 | 1.440 |
Why?
| Genomics | 16 | 2025 | 716 | 1.420 |
Why?
| Megakaryocytes | 3 | 2021 | 32 | 1.310 |
Why?
| Phenotype | 50 | 2025 | 3076 | 1.240 |
Why?
| Quantitative Trait Loci | 18 | 2025 | 355 | 1.220 |
Why?
| Genetic Loci | 18 | 2021 | 275 | 1.210 |
Why?
| Fatty Acids, Omega-6 | 5 | 2017 | 47 | 1.190 |
Why?
| Humans | 232 | 2025 | 129650 | 1.160 |
Why?
| Multigene Family | 9 | 2021 | 199 | 1.070 |
Why?
| Coronary Artery Disease | 11 | 2025 | 679 | 1.060 |
Why?
| Receptors, Cell Surface | 8 | 2024 | 380 | 1.020 |
Why?
| DNA Methylation | 6 | 2024 | 607 | 0.990 |
Why?
| Gene Frequency | 23 | 2024 | 503 | 0.990 |
Why?
| Genetics, Population | 14 | 2021 | 200 | 0.950 |
Why?
| Linoleic Acid | 6 | 2023 | 41 | 0.920 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 12 | 2022 | 103 | 0.900 |
Why?
| Nasal Mucosa | 2 | 2024 | 107 | 0.900 |
Why?
| Tacrolimus Binding Proteins | 1 | 2024 | 27 | 0.900 |
Why?
| Allergens | 5 | 2023 | 385 | 0.870 |
Why?
| Hypersensitivity, Immediate | 2 | 2023 | 43 | 0.860 |
Why?
| Transcriptome | 3 | 2022 | 887 | 0.840 |
Why?
| Genetic Linkage | 14 | 2022 | 299 | 0.830 |
Why?
| Models, Genetic | 14 | 2025 | 594 | 0.820 |
Why?
| HLA-DQ alpha-Chains | 2 | 2022 | 16 | 0.800 |
Why?
| Chromosome Mapping | 16 | 2021 | 504 | 0.780 |
Why?
| 2S Albumins, Plant | 1 | 2022 | 29 | 0.750 |
Why?
| Linkage Disequilibrium | 19 | 2022 | 257 | 0.750 |
Why?
| Antigens, Plant | 1 | 2022 | 48 | 0.740 |
Why?
| Pulmonary Disease, Chronic Obstructive | 11 | 2021 | 985 | 0.740 |
Why?
| Mosaicism | 4 | 2025 | 71 | 0.740 |
Why?
| Nucleotide Transport Proteins | 1 | 2021 | 1 | 0.730 |
Why?
| High-Throughput Nucleotide Sequencing | 6 | 2019 | 487 | 0.730 |
Why?
| Male | 106 | 2025 | 63681 | 0.730 |
Why?
| Immunoglobulin G | 2 | 2022 | 847 | 0.710 |
Why?
| Lipids | 8 | 2023 | 625 | 0.700 |
Why?
| Female | 107 | 2025 | 68776 | 0.690 |
Why?
| Antibody Formation | 1 | 2022 | 290 | 0.680 |
Why?
| Platelet Function Tests | 3 | 2021 | 25 | 0.670 |
Why?
| Herpesvirus 1, Human | 1 | 2021 | 86 | 0.670 |
Why?
| Middle Aged | 66 | 2025 | 31154 | 0.660 |
Why?
| Genetic Association Studies | 13 | 2024 | 360 | 0.660 |
Why?
| Multifactorial Inheritance | 4 | 2025 | 150 | 0.650 |
Why?
| Open Reading Frames | 3 | 2021 | 117 | 0.610 |
Why?
| Lung | 9 | 2022 | 3930 | 0.600 |
Why?
| Fibrinogen | 7 | 2024 | 164 | 0.590 |
Why?
| Adult | 63 | 2024 | 35576 | 0.570 |
Why?
| Alzheimer Disease | 1 | 2023 | 519 | 0.560 |
Why?
| Computational Biology | 5 | 2025 | 599 | 0.540 |
Why?
| Chromosomes, Human, Pair 11 | 5 | 2014 | 56 | 0.530 |
Why?
| Human Migration | 1 | 2016 | 21 | 0.530 |
Why?
| Gene-Environment Interaction | 3 | 2014 | 185 | 0.520 |
Why?
| Pulmonary Emphysema | 3 | 2014 | 275 | 0.520 |
Why?
| Platelet Activation | 4 | 2018 | 91 | 0.510 |
Why?
| Gene Flow | 1 | 2016 | 76 | 0.500 |
Why?
| Software | 5 | 2024 | 608 | 0.490 |
Why?
| Case-Control Studies | 20 | 2025 | 3381 | 0.490 |
Why?
| Diabetes Mellitus, Type 2 | 10 | 2022 | 2441 | 0.480 |
Why?
| Evolution, Molecular | 3 | 2019 | 466 | 0.480 |
Why?
| von Willebrand Factor | 5 | 2024 | 70 | 0.460 |
Why?
| RNA | 1 | 2021 | 883 | 0.450 |
Why?
| Geography | 2 | 2016 | 188 | 0.450 |
Why?
| HLA-B7 Antigen | 1 | 2013 | 7 | 0.430 |
Why?
| Diet | 4 | 2023 | 1213 | 0.430 |
Why?
| Polymorphism, Genetic | 11 | 2017 | 640 | 0.430 |
Why?
| Fatty Acids, Unsaturated | 4 | 2020 | 97 | 0.430 |
Why?
| Epigenesis, Genetic | 6 | 2024 | 613 | 0.420 |
Why?
| Bronchial Hyperreactivity | 1 | 2014 | 105 | 0.420 |
Why?
| Risk Factors | 22 | 2025 | 9765 | 0.420 |
Why?
| Haplotypes | 13 | 2025 | 475 | 0.410 |
Why?
| Pedigree | 7 | 2020 | 487 | 0.410 |
Why?
| Quantitative Trait, Heritable | 6 | 2021 | 121 | 0.410 |
Why?
| Interferon-gamma | 3 | 2015 | 770 | 0.410 |
Why?
| Hypersensitivity | 4 | 2024 | 249 | 0.390 |
Why?
| Child | 30 | 2025 | 20883 | 0.390 |
Why?
| Airway Obstruction | 1 | 2014 | 152 | 0.380 |
Why?
| Fatty Acids, Omega-3 | 3 | 2021 | 138 | 0.370 |
Why?
| Immunity, Cellular | 1 | 2013 | 265 | 0.370 |
Why?
| Mutation | 9 | 2024 | 3717 | 0.370 |
Why?
| Leukocytes | 4 | 2023 | 304 | 0.360 |
Why?
| Likelihood Functions | 5 | 2012 | 138 | 0.360 |
Why?
| Stearoyl-CoA Desaturase | 1 | 2011 | 65 | 0.360 |
Why?
| Frailty | 2 | 2024 | 153 | 0.360 |
Why?
| Mendelian Randomization Analysis | 3 | 2024 | 47 | 0.360 |
Why?
| United States | 29 | 2024 | 13903 | 0.350 |
Why?
| Dyslipidemias | 3 | 2016 | 177 | 0.350 |
Why?
| Aging | 4 | 2023 | 1776 | 0.340 |
Why?
| Diabetes Mellitus | 4 | 2023 | 1001 | 0.340 |
Why?
| Telomere | 5 | 2024 | 232 | 0.340 |
Why?
| Cohort Studies | 15 | 2021 | 5420 | 0.340 |
Why?
| Genome | 4 | 2022 | 278 | 0.330 |
Why?
| DNA, Mitochondrial | 2 | 2023 | 191 | 0.330 |
Why?
| Factor VIII | 2 | 2024 | 87 | 0.330 |
Why?
| Gene Expression Regulation | 9 | 2024 | 2548 | 0.330 |
Why?
| Cell Adhesion Molecules | 2 | 2024 | 173 | 0.330 |
Why?
| RNA, Long Noncoding | 2 | 2023 | 179 | 0.330 |
Why?
| Adolescent | 27 | 2023 | 20393 | 0.330 |
Why?
| Aged | 32 | 2025 | 22103 | 0.330 |
Why?
| Healthcare Disparities | 3 | 2025 | 578 | 0.320 |
Why?
| Biomarkers | 7 | 2024 | 3973 | 0.320 |
Why?
| Computer Simulation | 8 | 2024 | 943 | 0.310 |
Why?
| Organ Specificity | 2 | 2021 | 296 | 0.310 |
Why?
| Chromosome Aberrations | 2 | 2024 | 150 | 0.300 |
Why?
| Adaptation, Physiological | 1 | 2012 | 513 | 0.300 |
Why?
| Smoking | 6 | 2018 | 1501 | 0.300 |
Why?
| Genetic Pleiotropy | 3 | 2019 | 29 | 0.300 |
Why?
| Dietary Fats | 1 | 2010 | 301 | 0.300 |
Why?
| Pharmacogenetics | 2 | 2020 | 175 | 0.300 |
Why?
| Gene Regulatory Networks | 2 | 2024 | 284 | 0.290 |
Why?
| HLA-DQ beta-Chains | 2 | 2021 | 61 | 0.290 |
Why?
| Arachidonic Acid | 6 | 2015 | 115 | 0.280 |
Why?
| Fasting | 2 | 2022 | 267 | 0.280 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2013 | 857 | 0.280 |
Why?
| Body Height | 4 | 2015 | 193 | 0.270 |
Why?
| Loss of Function Mutation | 3 | 2021 | 39 | 0.270 |
Why?
| Restless Legs Syndrome | 1 | 2006 | 21 | 0.260 |
Why?
| Aspirin | 4 | 2018 | 380 | 0.260 |
Why?
| Carboxylic Ester Hydrolases | 1 | 2006 | 20 | 0.260 |
Why?
| Cardiovascular Diseases | 7 | 2020 | 2004 | 0.260 |
Why?
| Computer Graphics | 1 | 2006 | 41 | 0.260 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 69 | 0.260 |
Why?
| Schistosoma japonicum | 2 | 2017 | 31 | 0.250 |
Why?
| Biological Specimen Banks | 3 | 2024 | 98 | 0.250 |
Why?
| Health Status Disparities | 3 | 2025 | 254 | 0.250 |
Why?
| Lipoprotein Lipase | 1 | 2006 | 59 | 0.250 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 769 | 0.250 |
Why?
| Hematopoietic Stem Cells | 3 | 2024 | 381 | 0.240 |
Why?
| Serine | 1 | 2006 | 138 | 0.240 |
Why?
| Blood Proteins | 2 | 2024 | 242 | 0.240 |
Why?
| Helminthiasis | 2 | 2017 | 11 | 0.240 |
Why?
| Endophenotypes | 1 | 2025 | 18 | 0.240 |
Why?
| Models, Statistical | 7 | 2021 | 623 | 0.240 |
Why?
| Liver | 6 | 2024 | 1839 | 0.240 |
Why?
| Hematopoiesis | 2 | 2023 | 183 | 0.240 |
Why?
| Genomic Structural Variation | 1 | 2025 | 12 | 0.240 |
Why?
| Membrane Proteins | 7 | 2017 | 1119 | 0.240 |
Why?
| Germ-Line Mutation | 2 | 2023 | 140 | 0.240 |
Why?
| Chromosomes, Human, Y | 1 | 2025 | 20 | 0.240 |
Why?
| Inflammation | 6 | 2024 | 2736 | 0.230 |
Why?
| Cholesterol, HDL | 4 | 2016 | 205 | 0.230 |
Why?
| Young Adult | 13 | 2022 | 12426 | 0.230 |
Why?
| Consanguinity | 2 | 2005 | 47 | 0.230 |
Why?
| Chromosome Deletion | 1 | 2025 | 104 | 0.230 |
Why?
| Tomography, X-Ray Computed | 2 | 2014 | 2535 | 0.230 |
Why?
| Kininogens | 1 | 2024 | 6 | 0.230 |
Why?
| Chromosomes, Human, Pair 16 | 3 | 2021 | 30 | 0.220 |
Why?
| Telomere Homeostasis | 1 | 2024 | 29 | 0.220 |
Why?
| Lectins, C-Type | 1 | 2024 | 71 | 0.220 |
Why?
| Interleukin-13 | 3 | 2023 | 147 | 0.220 |
Why?
| Chemokines, CC | 2 | 2014 | 33 | 0.220 |
Why?
| Liver Cirrhosis | 2 | 2017 | 280 | 0.220 |
Why?
| Forced Expiratory Volume | 4 | 2019 | 510 | 0.220 |
Why?
| Blood Pressure | 6 | 2022 | 1736 | 0.220 |
Why?
| Fibronectins | 1 | 2024 | 123 | 0.210 |
Why?
| Menopause, Premature | 1 | 2023 | 9 | 0.210 |
Why?
| Population Groups | 3 | 2019 | 60 | 0.210 |
Why?
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 2 | 2022 | 2 | 0.210 |
Why?
| Erythrocytes | 2 | 2021 | 672 | 0.210 |
Why?
| Barbados | 8 | 2013 | 8 | 0.210 |
Why?
| Proteomics | 3 | 2024 | 1062 | 0.210 |
Why?
| Respiration | 2 | 2014 | 191 | 0.210 |
Why?
| Metabolic Syndrome | 3 | 2011 | 339 | 0.210 |
Why?
| Blood Cells | 1 | 2022 | 39 | 0.200 |
Why?
| Frameshift Mutation | 1 | 2022 | 32 | 0.200 |
Why?
| Interleukin-4 | 2 | 2023 | 212 | 0.200 |
Why?
| Promoter Regions, Genetic | 6 | 2023 | 1207 | 0.200 |
Why?
| Chromosomes, Human, X | 2 | 2021 | 72 | 0.200 |
Why?
| Proteome | 2 | 2024 | 443 | 0.200 |
Why?
| Telomere Shortening | 1 | 2022 | 20 | 0.200 |
Why?
| Eczema | 1 | 2023 | 67 | 0.190 |
Why?
| Acute Coronary Syndrome | 2 | 2016 | 267 | 0.190 |
Why?
| Desensitization, Immunologic | 1 | 2023 | 90 | 0.190 |
Why?
| Genetic Heterogeneity | 3 | 2016 | 58 | 0.190 |
Why?
| Gastritis | 1 | 2023 | 96 | 0.190 |
Why?
| Nerve Tissue Proteins | 5 | 2022 | 570 | 0.190 |
Why?
| Coronary Disease | 2 | 2019 | 385 | 0.190 |
Why?
| Enteritis | 1 | 2023 | 93 | 0.190 |
Why?
| Pseudomonas Infections | 2 | 2015 | 221 | 0.190 |
Why?
| HLA-A2 Antigen | 1 | 2021 | 48 | 0.190 |
Why?
| Social Determinants of Health | 1 | 2025 | 221 | 0.180 |
Why?
| Dinoprostone | 1 | 2022 | 186 | 0.180 |
Why?
| Americas | 1 | 2021 | 24 | 0.180 |
Why?
| Spain | 1 | 2021 | 34 | 0.180 |
Why?
| Cyclooxygenase Inhibitors | 2 | 2014 | 80 | 0.180 |
Why?
| Peru | 1 | 2021 | 53 | 0.180 |
Why?
| Pulmonary Medicine | 2 | 2019 | 79 | 0.180 |
Why?
| DNA Copy Number Variations | 2 | 2020 | 170 | 0.180 |
Why?
| Gene Ontology | 1 | 2021 | 51 | 0.180 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2021 | 84 | 0.180 |
Why?
| Odds Ratio | 7 | 2019 | 1023 | 0.180 |
Why?
| Glutathione Transferase | 1 | 2021 | 101 | 0.180 |
Why?
| Cytokines | 4 | 2023 | 2017 | 0.180 |
Why?
| Lipid Metabolism | 2 | 2021 | 497 | 0.170 |
Why?
| Risk | 7 | 2019 | 854 | 0.170 |
Why?
| Immunologic Factors | 1 | 2022 | 231 | 0.170 |
Why?
| gamma-Linolenic Acid | 1 | 2020 | 2 | 0.170 |
Why?
| Chromosomes, Human, Pair 19 | 3 | 2012 | 23 | 0.170 |
Why?
| Receptors, Nicotinic | 2 | 2013 | 329 | 0.170 |
Why?
| Energy Intake | 1 | 2023 | 461 | 0.170 |
Why?
| Plant Oils | 1 | 2020 | 29 | 0.170 |
Why?
| Soybean Oil | 1 | 2020 | 14 | 0.170 |
Why?
| HLA-DQ Antigens | 1 | 2021 | 179 | 0.170 |
Why?
| Amish | 1 | 2020 | 7 | 0.170 |
Why?
| Platelet Aggregation Inhibitors | 2 | 2018 | 442 | 0.170 |
Why?
| Thrombosis | 5 | 2024 | 343 | 0.170 |
Why?
| beta-Globins | 1 | 2019 | 8 | 0.170 |
Why?
| Base Sequence | 4 | 2021 | 2142 | 0.170 |
Why?
| Genomic Instability | 1 | 2020 | 48 | 0.160 |
Why?
| Occipital Lobe | 1 | 2019 | 24 | 0.160 |
Why?
| Cholesterol, LDL | 5 | 2022 | 358 | 0.160 |
Why?
| Tissue Plasminogen Activator | 1 | 2021 | 222 | 0.160 |
Why?
| Homozygote | 3 | 2016 | 193 | 0.160 |
Why?
| Diabetic Nephropathies | 1 | 2023 | 284 | 0.160 |
Why?
| HLA-DRB1 Chains | 1 | 2020 | 108 | 0.160 |
Why?
| Mutation, Missense | 2 | 2023 | 317 | 0.160 |
Why?
| 8,11,14-Eicosatrienoic Acid | 3 | 2020 | 6 | 0.160 |
Why?
| Eicosanoids | 2 | 2022 | 57 | 0.160 |
Why?
| Parietal Lobe | 1 | 2019 | 49 | 0.160 |
Why?
| Clinical Trials as Topic | 2 | 2022 | 1004 | 0.160 |
Why?
| Chromosomes, Human, Pair 12 | 4 | 2019 | 21 | 0.160 |
Why?
| Photometry | 1 | 2019 | 4 | 0.160 |
Why?
| Flame Retardants | 1 | 2019 | 8 | 0.160 |
Why?
| Genes, Mitochondrial | 1 | 2018 | 13 | 0.160 |
Why?
| Th2 Cells | 4 | 2023 | 171 | 0.160 |
Why?
| Metabolomics | 2 | 2024 | 652 | 0.160 |
Why?
| Chromatography, Gas | 1 | 2019 | 32 | 0.160 |
Why?
| Plasticizers | 1 | 2019 | 14 | 0.160 |
Why?
| Sleep Medicine Specialty | 1 | 2019 | 9 | 0.160 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2025 | 51 | 0.160 |
Why?
| Brazil | 6 | 2017 | 154 | 0.160 |
Why?
| India | 3 | 2009 | 170 | 0.160 |
Why?
| Temporal Lobe | 1 | 2019 | 87 | 0.150 |
Why?
| Sex Characteristics | 3 | 2014 | 737 | 0.150 |
Why?
| Receptors, Immunologic | 3 | 2022 | 216 | 0.150 |
Why?
| Metabolism | 1 | 2018 | 38 | 0.150 |
Why?
| Brain | 2 | 2023 | 2679 | 0.150 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2018 | 9 | 0.150 |
Why?
| Family | 4 | 2012 | 657 | 0.150 |
Why?
| Databases, Genetic | 4 | 2021 | 232 | 0.150 |
Why?
| Smad2 Protein | 1 | 2018 | 38 | 0.150 |
Why?
| Eosinophilic Esophagitis | 1 | 2023 | 318 | 0.150 |
Why?
| Child, Preschool | 16 | 2021 | 10517 | 0.150 |
Why?
| Blood Glucose | 4 | 2021 | 2097 | 0.150 |
Why?
| Hominidae | 1 | 2019 | 81 | 0.150 |
Why?
| Computer Communication Networks | 1 | 2018 | 32 | 0.150 |
Why?
| Indians, North American | 2 | 2021 | 600 | 0.150 |
Why?
| Frontal Lobe | 1 | 2019 | 154 | 0.150 |
Why?
| Exons | 3 | 2016 | 342 | 0.150 |
Why?
| Immunotherapy | 1 | 2022 | 592 | 0.150 |
Why?
| Telomerase | 2 | 2024 | 233 | 0.150 |
Why?
| Organophosphates | 1 | 2019 | 120 | 0.140 |
Why?
| Lipopolysaccharide Receptors | 2 | 2010 | 87 | 0.140 |
Why?
| Comorbidity | 1 | 2023 | 1547 | 0.140 |
Why?
| Pulmonary Surfactant-Associated Protein D | 1 | 2017 | 35 | 0.140 |
Why?
| DNA-Binding Proteins | 3 | 2020 | 1443 | 0.140 |
Why?
| Molecular Targeted Therapy | 1 | 2020 | 390 | 0.140 |
Why?
| Africa | 2 | 2020 | 99 | 0.140 |
Why?
| Noncommunicable Diseases | 1 | 2017 | 15 | 0.140 |
Why?
| Information Storage and Retrieval | 1 | 2018 | 108 | 0.140 |
Why?
| Quality Control | 4 | 2021 | 163 | 0.140 |
Why?
| Algorithms | 6 | 2025 | 1622 | 0.140 |
Why?
| Hyaluronoglucosaminidase | 1 | 2017 | 8 | 0.140 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 87 | 0.140 |
Why?
| Aged, 80 and over | 9 | 2020 | 7086 | 0.140 |
Why?
| Molecular Epidemiology | 3 | 2013 | 63 | 0.140 |
Why?
| Schistosoma mansoni | 1 | 2017 | 37 | 0.140 |
Why?
| Academic Medical Centers | 1 | 2020 | 481 | 0.140 |
Why?
| Glomerular Filtration Rate | 1 | 2021 | 711 | 0.130 |
Why?
| Endemic Diseases | 1 | 2017 | 31 | 0.130 |
Why?
| Renal Insufficiency, Chronic | 1 | 2023 | 566 | 0.130 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 26 | 0.130 |
Why?
| Decision Support Systems, Clinical | 1 | 2020 | 205 | 0.130 |
Why?
| Sequence Analysis, DNA | 6 | 2018 | 779 | 0.130 |
Why?
| Scavenger Receptors, Class B | 1 | 2016 | 11 | 0.130 |
Why?
| DNA, Intergenic | 1 | 2016 | 24 | 0.130 |
Why?
| Cyclooxygenase 1 | 2 | 2014 | 26 | 0.130 |
Why?
| Schistosomiasis | 1 | 2017 | 47 | 0.130 |
Why?
| Enhancer Elements, Genetic | 1 | 2017 | 177 | 0.130 |
Why?
| Carotid Artery Diseases | 1 | 2016 | 64 | 0.130 |
Why?
| White Matter | 1 | 2018 | 136 | 0.130 |
Why?
| Erythropoiesis | 1 | 2016 | 51 | 0.130 |
Why?
| Myocardial Infarction | 2 | 2020 | 1022 | 0.130 |
Why?
| Adrenal Cortex Hormones | 1 | 2019 | 522 | 0.130 |
Why?
| Immune System Diseases | 1 | 2016 | 34 | 0.130 |
Why?
| Animals | 18 | 2023 | 35361 | 0.130 |
Why?
| Transforming Growth Factor beta1 | 1 | 2017 | 157 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2018 | 248 | 0.130 |
Why?
| Lung Diseases, Interstitial | 1 | 2022 | 616 | 0.130 |
Why?
| Kidney Transplantation | 2 | 2012 | 672 | 0.130 |
Why?
| Sexism | 1 | 2016 | 55 | 0.130 |
Why?
| Cell Differentiation | 2 | 2021 | 1902 | 0.130 |
Why?
| Lipoprotein(a) | 1 | 2016 | 67 | 0.130 |
Why?
| United Kingdom | 3 | 2021 | 257 | 0.120 |
Why?
| Anthropometry | 2 | 2022 | 204 | 0.120 |
Why?
| Leukocytes, Mononuclear | 2 | 2021 | 545 | 0.120 |
Why?
| Genes, Modifier | 1 | 2015 | 2 | 0.120 |
Why?
| Caveolin 2 | 1 | 2015 | 2 | 0.120 |
Why?
| Respiratory Tract Diseases | 1 | 2017 | 148 | 0.120 |
Why?
| CpG Islands | 3 | 2023 | 152 | 0.120 |
Why?
| Factor VII | 1 | 2015 | 22 | 0.120 |
Why?
| Molecular Sequence Annotation | 3 | 2021 | 87 | 0.120 |
Why?
| Receptors, Interferon | 1 | 2015 | 50 | 0.120 |
Why?
| Collagen | 2 | 2015 | 434 | 0.120 |
Why?
| Schistosomiasis japonica | 1 | 2015 | 32 | 0.120 |
Why?
| Minority Groups | 1 | 2017 | 249 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 25 | 0.120 |
Why?
| Adenosine Triphosphatases | 1 | 2016 | 161 | 0.120 |
Why?
| Scleroderma, Systemic | 1 | 2016 | 114 | 0.120 |
Why?
| Menopause | 2 | 2023 | 297 | 0.120 |
Why?
| Interleukin-10 | 2 | 2017 | 304 | 0.120 |
Why?
| Mutant Chimeric Proteins | 1 | 2014 | 4 | 0.120 |
Why?
| Severity of Illness Index | 4 | 2019 | 2742 | 0.120 |
Why?
| KCNQ1 Potassium Channel | 1 | 2014 | 7 | 0.120 |
Why?
| HMGA2 Protein | 1 | 2014 | 9 | 0.120 |
Why?
| HLA-B27 Antigen | 1 | 2014 | 15 | 0.110 |
Why?
| Chromosome Disorders | 1 | 2014 | 40 | 0.110 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 22 | 0.110 |
Why?
| Hypertension | 2 | 2022 | 1242 | 0.110 |
Why?
| Cystic Fibrosis | 2 | 2015 | 1053 | 0.110 |
Why?
| Rhinitis, Allergic | 1 | 2014 | 38 | 0.110 |
Why?
| Body Mass Index | 5 | 2022 | 2273 | 0.110 |
Why?
| Family Health | 4 | 2011 | 198 | 0.110 |
Why?
| Obesity | 2 | 2022 | 2883 | 0.110 |
Why?
| Critical Care | 1 | 2019 | 553 | 0.110 |
Why?
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 3 | 0.110 |
Why?
| Stroke | 1 | 2022 | 1071 | 0.110 |
Why?
| beta-Defensins | 1 | 2013 | 21 | 0.110 |
Why?
| Longitudinal Studies | 5 | 2021 | 2717 | 0.110 |
Why?
| Tobacco Use Disorder | 2 | 2013 | 237 | 0.110 |
Why?
| Vital Capacity | 1 | 2014 | 291 | 0.110 |
Why?
| Pseudomonas aeruginosa | 2 | 2015 | 347 | 0.110 |
Why?
| Dietary Supplements | 1 | 2017 | 534 | 0.110 |
Why?
| Kv Channel-Interacting Proteins | 1 | 2013 | 3 | 0.100 |
Why?
| Chemokine CXCL12 | 1 | 2013 | 79 | 0.100 |
Why?
| Cells, Cultured | 1 | 2021 | 4083 | 0.100 |
Why?
| Chromosomes, Human, Pair 1 | 2 | 2011 | 71 | 0.100 |
Why?
| Virginia | 2 | 2005 | 60 | 0.100 |
Why?
| Cross-Sectional Studies | 5 | 2024 | 5066 | 0.100 |
Why?
| Parents | 3 | 2007 | 1309 | 0.100 |
Why?
| HEK293 Cells | 3 | 2021 | 697 | 0.100 |
Why?
| Genetic Markers | 5 | 2016 | 338 | 0.100 |
Why?
| Nuclear Proteins | 1 | 2017 | 663 | 0.100 |
Why?
| K562 Cells | 2 | 2024 | 86 | 0.100 |
Why?
| Principal Component Analysis | 2 | 2010 | 189 | 0.100 |
Why?
| Skin Tests | 4 | 2017 | 100 | 0.100 |
Why?
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2012 | 8 | 0.100 |
Why?
| Ankyrins | 1 | 2012 | 9 | 0.100 |
Why?
| Kallikreins | 1 | 2012 | 29 | 0.100 |
Why?
| Duffy Blood-Group System | 2 | 2011 | 6 | 0.100 |
Why?
| Phylogeny | 1 | 2016 | 852 | 0.100 |
Why?
| Fatty Acids | 1 | 2015 | 427 | 0.100 |
Why?
| Mitochondria | 1 | 2018 | 877 | 0.100 |
Why?
| Microbiota | 1 | 2020 | 730 | 0.100 |
Why?
| Atherosclerosis | 1 | 2016 | 402 | 0.100 |
Why?
| Triglycerides | 3 | 2015 | 527 | 0.100 |
Why?
| Leukocyte Count | 2 | 2011 | 326 | 0.100 |
Why?
| Respiratory Sounds | 1 | 2012 | 118 | 0.100 |
Why?
| Insulin | 4 | 2022 | 2326 | 0.090 |
Why?
| Prostate-Specific Antigen | 1 | 2012 | 162 | 0.090 |
Why?
| Infant | 9 | 2021 | 9024 | 0.090 |
Why?
| Steroids | 1 | 2012 | 158 | 0.090 |
Why?
| Heterozygote | 3 | 2021 | 272 | 0.090 |
Why?
| Reproducibility of Results | 6 | 2021 | 3083 | 0.090 |
Why?
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 16 | 0.090 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2011 | 39 | 0.090 |
Why?
| Aquaporin 5 | 1 | 2010 | 2 | 0.090 |
Why?
| Disease Progression | 5 | 2019 | 2635 | 0.090 |
Why?
| Microtubule-Associated Proteins | 1 | 2012 | 192 | 0.090 |
Why?
| Chromosomes | 1 | 2011 | 101 | 0.090 |
Why?
| Heredity | 2 | 2021 | 12 | 0.090 |
Why?
| Cockroaches | 1 | 2010 | 20 | 0.090 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2010 | 28 | 0.090 |
Why?
| Interviews as Topic | 2 | 2006 | 717 | 0.090 |
Why?
| Mice | 10 | 2023 | 16937 | 0.090 |
Why?
| Recombination, Genetic | 1 | 2011 | 190 | 0.090 |
Why?
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2009 | 2 | 0.080 |
Why?
| Incidence | 4 | 2019 | 2644 | 0.080 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 1 | 2010 | 37 | 0.080 |
Why?
| Eosinophils | 2 | 2025 | 324 | 0.080 |
Why?
| Health Services Accessibility | 1 | 2017 | 902 | 0.080 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3408 | 0.080 |
Why?
| Myocardial Ischemia | 1 | 2011 | 258 | 0.080 |
Why?
| Lectins | 1 | 2010 | 46 | 0.080 |
Why?
| Receptors, Kainic Acid | 1 | 2009 | 9 | 0.080 |
Why?
| Nuclear Family | 2 | 2007 | 51 | 0.080 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 63 | 0.080 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2009 | 73 | 0.080 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 9 | 0.080 |
Why?
| Isoenzymes | 1 | 2010 | 302 | 0.080 |
Why?
| Chromosomes, Human | 1 | 2009 | 41 | 0.080 |
Why?
| Machine Learning | 2 | 2025 | 443 | 0.080 |
Why?
| Tryptophan | 1 | 2010 | 179 | 0.080 |
Why?
| Caribbean Region | 4 | 2011 | 25 | 0.080 |
Why?
| Receptors, Leptin | 1 | 2009 | 23 | 0.080 |
Why?
| Confidence Intervals | 2 | 2014 | 317 | 0.080 |
Why?
| Interferon-alpha | 1 | 2010 | 194 | 0.080 |
Why?
| Arginine | 1 | 2010 | 265 | 0.080 |
Why?
| Nephrotic Syndrome | 1 | 1989 | 28 | 0.080 |
Why?
| Agammaglobulinemia | 1 | 1989 | 33 | 0.080 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 56 | 0.080 |
Why?
| Regression Analysis | 3 | 2025 | 993 | 0.080 |
Why?
| Graft Rejection | 1 | 2012 | 598 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2022 | 375 | 0.080 |
Why?
| Genotyping Techniques | 2 | 2019 | 72 | 0.070 |
Why?
| Thromboxane B2 | 3 | 2018 | 26 | 0.070 |
Why?
| Cholesterol | 2 | 2015 | 412 | 0.070 |
Why?
| Proteoglycans | 1 | 2009 | 110 | 0.070 |
Why?
| Alcoholism | 3 | 2005 | 766 | 0.070 |
Why?
| Siblings | 2 | 2011 | 215 | 0.070 |
Why?
| Polymerase Chain Reaction | 2 | 2012 | 1038 | 0.070 |
Why?
| Research Design | 2 | 2019 | 1044 | 0.070 |
Why?
| Chromosomes, Human, Pair 17 | 3 | 2019 | 54 | 0.070 |
Why?
| Cognition | 1 | 2015 | 1123 | 0.070 |
Why?
| Myosin-Light-Chain Kinase | 1 | 2007 | 20 | 0.070 |
Why?
| Immunosuppressive Agents | 1 | 2012 | 853 | 0.070 |
Why?
| Antigens, CD | 1 | 2010 | 489 | 0.070 |
Why?
| Databases, Factual | 1 | 2012 | 1269 | 0.070 |
Why?
| Infant, Newborn | 6 | 2012 | 5762 | 0.070 |
Why?
| Age of Onset | 3 | 2013 | 496 | 0.070 |
Why?
| Registries | 1 | 2014 | 1896 | 0.070 |
Why?
| Inheritance Patterns | 1 | 2006 | 46 | 0.070 |
Why?
| Thrombophilia | 1 | 2007 | 81 | 0.070 |
Why?
| Deoxyribonuclease HindIII | 1 | 2006 | 3 | 0.060 |
Why?
| alpha-Linolenic Acid | 2 | 2017 | 8 | 0.060 |
Why?
| Europe | 2 | 2020 | 364 | 0.060 |
Why?
| Meta-Analysis as Topic | 3 | 2012 | 170 | 0.060 |
Why?
| Prospective Studies | 5 | 2020 | 7133 | 0.060 |
Why?
| Adenosine Diphosphate | 2 | 2017 | 80 | 0.060 |
Why?
| Neoplasm Proteins | 2 | 2022 | 424 | 0.060 |
Why?
| Platelet Count | 2 | 2016 | 82 | 0.060 |
Why?
| Chromosomes, Human, Pair 4 | 2 | 2019 | 29 | 0.060 |
Why?
| DNA Mutational Analysis | 2 | 2020 | 387 | 0.060 |
Why?
| Epinephrine | 2 | 2017 | 141 | 0.060 |
Why?
| Glucose | 2 | 2022 | 1003 | 0.060 |
Why?
| Transfection | 3 | 2016 | 911 | 0.060 |
Why?
| Mucins | 1 | 2005 | 70 | 0.060 |
Why?
| Complement C3 | 1 | 2006 | 203 | 0.060 |
Why?
| Receptors, Prostaglandin | 1 | 2004 | 22 | 0.060 |
Why?
| Immunoglobulins | 1 | 2005 | 159 | 0.060 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 25 | 0.060 |
Why?
| Mites | 1 | 2004 | 6 | 0.060 |
Why?
| Janus Kinase 2 | 1 | 2024 | 32 | 0.060 |
Why?
| Loss of Heterozygosity | 1 | 2024 | 46 | 0.060 |
Why?
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 21 | 0.060 |
Why?
| Hypertension, Pulmonary | 1 | 2016 | 1894 | 0.060 |
Why?
| Eye Proteins | 2 | 2021 | 88 | 0.060 |
Why?
| Gene Targeting | 2 | 2020 | 82 | 0.060 |
Why?
| Matched-Pair Analysis | 1 | 2003 | 40 | 0.050 |
Why?
| Adult Children | 1 | 2003 | 23 | 0.050 |
Why?
| Societies, Medical | 2 | 2019 | 751 | 0.050 |
Why?
| Chromosomes, Human, Pair 14 | 2 | 2014 | 19 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2014 | 4063 | 0.050 |
Why?
| Diabetic Retinopathy | 1 | 2006 | 176 | 0.050 |
Why?
| Time | 1 | 2003 | 75 | 0.050 |
Why?
| Receptors, Complement | 1 | 2004 | 122 | 0.050 |
Why?
| Epigenomics | 1 | 2024 | 110 | 0.050 |
Why?
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 2 | 0.050 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 101 | 0.050 |
Why?
| Sex Factors | 3 | 2014 | 1968 | 0.050 |
Why?
| Genes | 1 | 2003 | 226 | 0.050 |
Why?
| Electroencephalography | 1 | 2005 | 403 | 0.050 |
Why?
| Gene Expression Profiling | 1 | 2010 | 1706 | 0.050 |
Why?
| Point Mutation | 1 | 2004 | 225 | 0.050 |
Why?
| RNA, Messenger | 2 | 2016 | 2708 | 0.050 |
Why?
| Aminopeptidases | 1 | 2023 | 17 | 0.050 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 474 | 0.050 |
Why?
| CRISPR-Cas Systems | 1 | 2024 | 109 | 0.050 |
Why?
| Environment | 2 | 2010 | 343 | 0.050 |
Why?
| Cooperative Behavior | 1 | 2005 | 433 | 0.050 |
Why?
| Genes, Reporter | 2 | 2015 | 267 | 0.050 |
Why?
| Cell Line | 3 | 2015 | 2781 | 0.050 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 16 | 0.050 |
Why?
| Pruritus | 1 | 2023 | 58 | 0.050 |
Why?
| Syndrome | 1 | 2023 | 341 | 0.050 |
Why?
| Frail Elderly | 1 | 2023 | 121 | 0.050 |
Why?
| Fruit | 1 | 2023 | 131 | 0.050 |
Why?
| Vegetables | 1 | 2023 | 147 | 0.050 |
Why?
| Colorado | 2 | 2024 | 4421 | 0.050 |
Why?
| Age Factors | 3 | 2003 | 3144 | 0.050 |
Why?
| Gene Expression | 3 | 2015 | 1472 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2023 | 260 | 0.050 |
Why?
| RGS Proteins | 1 | 2021 | 16 | 0.050 |
Why?
| Internationality | 2 | 2013 | 149 | 0.050 |
Why?
| Postmenopause | 1 | 2023 | 351 | 0.050 |
Why?
| Subcutaneous Tissue | 1 | 2021 | 22 | 0.050 |
Why?
| INDEL Mutation | 1 | 2021 | 15 | 0.050 |
Why?
| Colombia | 2 | 2013 | 36 | 0.050 |
Why?
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 29 | 0.040 |
Why?
| Sepsis | 1 | 2007 | 574 | 0.040 |
Why?
| Prognosis | 2 | 2021 | 3794 | 0.040 |
Why?
| alpha Karyopherins | 1 | 2020 | 11 | 0.040 |
Why?
| Receptors, LDL | 1 | 2020 | 47 | 0.040 |
Why?
| Antibodies, Heterophile | 1 | 2000 | 14 | 0.040 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 82 | 0.040 |
Why?
| Datasets as Topic | 1 | 2021 | 110 | 0.040 |
Why?
| Tripartite Motif Proteins | 1 | 2020 | 29 | 0.040 |
Why?
| Lymphocytosis | 1 | 2000 | 10 | 0.040 |
Why?
| GTP-Binding Proteins | 1 | 2021 | 157 | 0.040 |
Why?
| Sample Size | 1 | 2021 | 116 | 0.040 |
Why?
| Public Health Surveillance | 1 | 2021 | 68 | 0.040 |
Why?
| Population Density | 1 | 2021 | 91 | 0.040 |
Why?
| Lod Score | 3 | 2009 | 66 | 0.040 |
Why?
| Dioxygenases | 1 | 2020 | 29 | 0.040 |
Why?
| Gene Editing | 1 | 2021 | 68 | 0.040 |
Why?
| Cell Self Renewal | 1 | 2020 | 53 | 0.040 |
Why?
| Interleukin-6 | 1 | 2024 | 720 | 0.040 |
Why?
| Eating | 1 | 2023 | 369 | 0.040 |
Why?
| Names | 1 | 2000 | 12 | 0.040 |
Why?
| Immunity, Innate | 1 | 2006 | 804 | 0.040 |
Why?
| Lens, Crystalline | 1 | 2001 | 122 | 0.040 |
Why?
| Mutagenesis | 1 | 2021 | 181 | 0.040 |
Why?
| Respiratory Function Tests | 2 | 2013 | 586 | 0.040 |
Why?
| Mucin-5B | 1 | 2022 | 217 | 0.040 |
Why?
| Cytochrome P-450 CYP2C19 | 1 | 2020 | 23 | 0.040 |
Why?
| Fibrinolysis | 1 | 2021 | 137 | 0.040 |
Why?
| Gene Silencing | 1 | 2020 | 190 | 0.040 |
Why?
| A549 Cells | 1 | 2019 | 59 | 0.040 |
Why?
| Emigration and Immigration | 1 | 2000 | 50 | 0.040 |
Why?
| North America | 2 | 2011 | 291 | 0.040 |
Why?
| Siberia | 1 | 2019 | 9 | 0.040 |
Why?
| Body Weight | 1 | 2003 | 940 | 0.040 |
Why?
| Information Dissemination | 1 | 2021 | 206 | 0.040 |
Why?
| Recombinases | 1 | 2019 | 5 | 0.040 |
Why?
| Flame Ionization | 1 | 2019 | 2 | 0.040 |
Why?
| Event-Related Potentials, P300 | 1 | 1999 | 14 | 0.040 |
Why?
| Cloud Computing | 1 | 2019 | 7 | 0.040 |
Why?
| Proportional Hazards Models | 2 | 2014 | 1201 | 0.040 |
Why?
| Waist-Hip Ratio | 1 | 2018 | 35 | 0.040 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2019 | 35 | 0.040 |
Why?
| Linear Models | 2 | 2017 | 819 | 0.040 |
Why?
| Monoamine Oxidase | 1 | 1999 | 27 | 0.040 |
Why?
| Cataract | 1 | 2001 | 208 | 0.040 |
Why?
| Prevalence | 2 | 2016 | 2564 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2022 | 586 | 0.040 |
Why?
| Limit of Detection | 1 | 2019 | 82 | 0.040 |
Why?
| Endothelial Cells | 1 | 2024 | 749 | 0.040 |
Why?
| RNA Splicing Factors | 1 | 2019 | 52 | 0.040 |
Why?
| Calibration | 1 | 2019 | 140 | 0.040 |
Why?
| Organ Size | 1 | 2019 | 447 | 0.040 |
Why?
| Reference Standards | 1 | 2019 | 177 | 0.040 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2018 | 10 | 0.040 |
Why?
| Disease Susceptibility | 2 | 2014 | 333 | 0.040 |
Why?
| Virus Diseases | 1 | 2000 | 211 | 0.040 |
Why?
| Skin | 1 | 2023 | 725 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2019 | 666 | 0.040 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 31 | 0.040 |
Why?
| Histone Code | 1 | 2017 | 31 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 442 | 0.040 |
Why?
| Neoplasms | 1 | 2012 | 2470 | 0.030 |
Why?
| Selection, Genetic | 1 | 2019 | 249 | 0.030 |
Why?
| Adipocytes | 1 | 2018 | 205 | 0.030 |
Why?
| Program Evaluation | 1 | 2021 | 875 | 0.030 |
Why?
| Apolipoprotein B-100 | 1 | 2016 | 10 | 0.030 |
Why?
| Apolipoprotein E2 | 1 | 2016 | 3 | 0.030 |
Why?
| Time Factors | 2 | 2019 | 6556 | 0.030 |
Why?
| Workflow | 1 | 2018 | 155 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2020 | 638 | 0.030 |
Why?
| GPI-Linked Proteins | 1 | 2017 | 68 | 0.030 |
Why?
| Alternative Splicing | 1 | 2019 | 218 | 0.030 |
Why?
| Pilot Projects | 1 | 2022 | 1587 | 0.030 |
Why?
| Interleukin-33 | 1 | 2017 | 48 | 0.030 |
Why?
| T-Lymphocytes | 1 | 2005 | 1928 | 0.030 |
Why?
| Demography | 1 | 2017 | 279 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2019 | 4897 | 0.030 |
Why?
| Cluster Analysis | 1 | 2018 | 482 | 0.030 |
Why?
| Denmark | 1 | 2016 | 44 | 0.030 |
Why?
| Mean Platelet Volume | 1 | 2016 | 3 | 0.030 |
Why?
| Data Accuracy | 1 | 2017 | 57 | 0.030 |
Why?
| Allelic Imbalance | 1 | 2016 | 8 | 0.030 |
Why?
| Massachusetts | 1 | 2017 | 159 | 0.030 |
Why?
| Erythrocyte Indices | 1 | 2016 | 27 | 0.030 |
Why?
| Blood Cell Count | 1 | 2016 | 52 | 0.030 |
Why?
| China | 1 | 2017 | 191 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2000 | 601 | 0.030 |
Why?
| Asymptomatic Diseases | 1 | 2016 | 84 | 0.030 |
Why?
| Hematocrit | 1 | 2016 | 93 | 0.030 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 90 | 0.030 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2014 | 1056 | 0.030 |
Why?
| DNA | 1 | 2023 | 1400 | 0.030 |
Why?
| Stearic Acids | 1 | 2015 | 15 | 0.030 |
Why?
| Sarcoglycans | 1 | 2015 | 4 | 0.030 |
Why?
| Computed Tomography Angiography | 1 | 2016 | 115 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2016 | 282 | 0.030 |
Why?
| Bias | 1 | 2016 | 196 | 0.030 |
Why?
| Lung Volume Measurements | 1 | 2015 | 45 | 0.030 |
Why?
| Double-Blind Method | 1 | 2020 | 1876 | 0.030 |
Why?
| Protein Transport | 1 | 2017 | 428 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2015 | 70 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2019 | 1502 | 0.030 |
Why?
| Kidney | 1 | 2023 | 1385 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| Vascular Calcification | 1 | 2016 | 107 | 0.030 |
Why?
| Nutritional Status | 1 | 2017 | 328 | 0.030 |
Why?
| Social Class | 1 | 2017 | 257 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 331 | 0.030 |
Why?
| Phosphoproteins | 1 | 2017 | 332 | 0.030 |
Why?
| Pneumothorax | 1 | 2014 | 38 | 0.030 |
Why?
| Coronary Angiography | 1 | 2016 | 306 | 0.030 |
Why?
| Leukotriene B4 | 1 | 2014 | 42 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 821 | 0.030 |
Why?
| Potassium Channels | 1 | 2015 | 149 | 0.030 |
Why?
| Host-Parasite Interactions | 1 | 2015 | 102 | 0.030 |
Why?
| Myosin Heavy Chains | 1 | 2015 | 170 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 92 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2018 | 2012 | 0.030 |
Why?
| Fibrosis | 1 | 2017 | 520 | 0.030 |
Why?
| Hemoglobins | 1 | 2016 | 339 | 0.030 |
Why?
| Health Policy | 1 | 2017 | 353 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 407 | 0.030 |
Why?
| Stress, Psychological | 1 | 2022 | 1066 | 0.030 |
Why?
| Diet, Western | 1 | 2014 | 79 | 0.030 |
Why?
| alpha 1-Antitrypsin | 1 | 2014 | 107 | 0.030 |
Why?
| Jamaica | 1 | 2013 | 2 | 0.030 |
Why?
| Up-Regulation | 1 | 2016 | 840 | 0.030 |
Why?
| District of Columbia | 1 | 2013 | 26 | 0.030 |
Why?
| Cotinine | 1 | 2013 | 75 | 0.030 |
Why?
| Metabolic Networks and Pathways | 1 | 2014 | 178 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2019 | 2406 | 0.030 |
Why?
| Gene Order | 1 | 2012 | 26 | 0.030 |
Why?
| Educational Status | 1 | 2015 | 470 | 0.030 |
Why?
| New York | 1 | 2013 | 128 | 0.030 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2012 | 18 | 0.030 |
Why?
| Dynactin Complex | 1 | 2012 | 4 | 0.030 |
Why?
| Surveys and Questionnaires | 2 | 2009 | 5406 | 0.030 |
Why?
| Immunity, Mucosal | 1 | 2013 | 94 | 0.020 |
Why?
| Untranslated Regions | 1 | 2012 | 3 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2014 | 857 | 0.020 |
Why?
| Wales | 1 | 2011 | 17 | 0.020 |
Why?
| Statistics, Nonparametric | 2 | 2005 | 422 | 0.020 |
Why?
| Adolescent Development | 1 | 2012 | 84 | 0.020 |
Why?
| Biological Evolution | 1 | 2015 | 427 | 0.020 |
Why?
| Chemokine CXCL2 | 1 | 2011 | 43 | 0.020 |
Why?
| England | 1 | 2011 | 72 | 0.020 |
Why?
| Canada | 1 | 2012 | 350 | 0.020 |
Why?
| Epidemiologic Methods | 1 | 2011 | 74 | 0.020 |
Why?
| X Chromosome Inactivation | 1 | 2011 | 23 | 0.020 |
Why?
| Eicosapentaenoic Acid | 1 | 2011 | 36 | 0.020 |
Why?
| Luciferases | 1 | 2011 | 148 | 0.020 |
Why?
| Microsatellite Repeats | 2 | 2003 | 164 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2014 | 505 | 0.020 |
Why?
| Overweight | 1 | 2015 | 531 | 0.020 |
Why?
| Costa Rica | 1 | 2010 | 16 | 0.020 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 386 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1720 | 0.020 |
Why?
| Artifacts | 1 | 2011 | 126 | 0.020 |
Why?
| Carrier Proteins | 1 | 2015 | 743 | 0.020 |
Why?
| Codon, Nonsense | 1 | 2010 | 39 | 0.020 |
Why?
| Age Distribution | 1 | 2011 | 372 | 0.020 |
Why?
| Salmeterol Xinafoate | 1 | 2010 | 41 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 359 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2011 | 129 | 0.020 |
Why?
| Introns | 1 | 2011 | 251 | 0.020 |
Why?
| Markov Chains | 1 | 2010 | 117 | 0.020 |
Why?
| Albuterol | 1 | 2010 | 103 | 0.020 |
Why?
| Nicotine | 1 | 2012 | 303 | 0.020 |
Why?
| Urban Population | 1 | 2012 | 441 | 0.020 |
Why?
| Plasmids | 1 | 2010 | 358 | 0.020 |
Why?
| Coculture Techniques | 1 | 2010 | 226 | 0.020 |
Why?
| Kainic Acid | 1 | 2009 | 34 | 0.020 |
Why?
| Acute Disease | 1 | 2012 | 980 | 0.020 |
Why?
| Waist Circumference | 1 | 2010 | 138 | 0.020 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2009 | 40 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1288 | 0.020 |
Why?
| DNA Replication | 1 | 2011 | 228 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 161 | 0.020 |
Why?
| Mice, Knockout | 2 | 2009 | 2871 | 0.020 |
Why?
| Bronchodilator Agents | 1 | 2010 | 243 | 0.020 |
Why?
| Disease | 1 | 2009 | 95 | 0.020 |
Why?
| Spirometry | 1 | 2009 | 257 | 0.020 |
Why?
| Korea | 1 | 2007 | 10 | 0.020 |
Why?
| Quality of Life | 1 | 2019 | 2704 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 1838 | 0.020 |
Why?
| beta-Thromboglobulin | 1 | 2007 | 3 | 0.020 |
Why?
| Risk Assessment | 1 | 2016 | 3240 | 0.020 |
Why?
| Binding Sites | 1 | 2010 | 1252 | 0.020 |
Why?
| Dendritic Cells | 1 | 2010 | 478 | 0.020 |
Why?
| Transcription Factors | 1 | 2014 | 1651 | 0.020 |
Why?
| Drug Resistance | 1 | 2007 | 166 | 0.020 |
Why?
| Models, Theoretical | 1 | 2009 | 547 | 0.020 |
Why?
| Receptor for Advanced Glycation End Products | 1 | 2006 | 31 | 0.020 |
Why?
| Genetic Testing | 2 | 1999 | 428 | 0.020 |
Why?
| False Positive Reactions | 1 | 2005 | 114 | 0.020 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2005 | 43 | 0.020 |
Why?
| Hepatitis A Antibodies | 1 | 2005 | 3 | 0.020 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2005 | 42 | 0.020 |
Why?
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2005 | 30 | 0.020 |
Why?
| Hepatitis A | 1 | 2005 | 25 | 0.010 |
Why?
| Receptors, Virus | 1 | 2005 | 83 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2004 | 28 | 0.010 |
Why?
| Seroepidemiologic Studies | 1 | 2005 | 156 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2009 | 1698 | 0.010 |
Why?
| Antigens, Dermatophagoides | 1 | 2004 | 10 | 0.010 |
Why?
| U937 Cells | 1 | 2004 | 24 | 0.010 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2004 | 16 | 0.010 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 141 | 0.010 |
Why?
| Treatment Outcome | 1 | 2018 | 10230 | 0.010 |
Why?
| Gene Deletion | 1 | 2006 | 379 | 0.010 |
Why?
| Germany | 1 | 2004 | 100 | 0.010 |
Why?
| Receptor, Anaphylatoxin C5a | 1 | 2004 | 30 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2004 | 138 | 0.010 |
Why?
| Hyperglycemia | 1 | 2007 | 328 | 0.010 |
Why?
| Aquaporins | 1 | 2001 | 8 | 0.010 |
Why?
| Chimera | 1 | 2001 | 59 | 0.010 |
Why?
| Osmosis | 1 | 2001 | 17 | 0.010 |
Why?
| Crosses, Genetic | 1 | 2001 | 142 | 0.010 |
Why?
| Optics and Photonics | 1 | 2001 | 41 | 0.010 |
Why?
| Permeability | 1 | 2001 | 157 | 0.010 |
Why?
| Western Australia | 1 | 2001 | 6 | 0.010 |
Why?
| Lasers | 1 | 2001 | 132 | 0.010 |
Why?
| HIV-2 | 1 | 2000 | 18 | 0.010 |
Why?
| Cost Control | 1 | 2000 | 39 | 0.010 |
Why?
| Herpesvirus 6, Human | 1 | 2000 | 13 | 0.010 |
Why?
| Toxoplasma | 1 | 2000 | 37 | 0.010 |
Why?
| Cytomegalovirus | 1 | 2000 | 154 | 0.010 |
Why?
| Herpesvirus 4, Human | 1 | 2000 | 153 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2004 | 2832 | 0.010 |
Why?
| Expert Testimony | 1 | 1999 | 36 | 0.010 |
Why?
| Immunoglobulin M | 1 | 2000 | 275 | 0.010 |
Why?
| Observer Variation | 1 | 1999 | 315 | 0.010 |
Why?
| Lymphocytes | 1 | 2000 | 377 | 0.010 |
Why?
| Water | 1 | 2001 | 448 | 0.010 |
Why?
| Eosinophilia | 1 | 1999 | 204 | 0.010 |
Why?
| HIV-1 | 1 | 2000 | 836 | 0.010 |
Why?
| Physicians | 1 | 1999 | 865 | 0.010 |
Why?
|
|
Mathias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|